World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
126
Citations
60379
World Ranking
419
National Ranking
252

Medicine

D-Index
127
Citations
63268
World Ranking
2817
National Ranking
1568

Alice B. Gottlieb publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alice B. Gottlieb sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 786 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alice B. Gottlieb D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alice B. Gottlieb sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 127 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Alice B. Gottlieb is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a significant number of publications in Immunology, Rheumatology, Dermatology, Hematology, and Economics and Econometrics.

Their work covers several main topics, including:

  • Psoriasis: Treatment and Pathogenesis
  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Dermatology and Skin Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune Bullous Skin Diseases

They have published extensively in several journals, notably:

  • Journal of the American Academy of Dermatology
  • SKIN The Journal of Cutaneous Medicine
  • Annals of the Rheumatic Diseases
  • Dermatology and Therapy
  • The Journal of Rheumatology

Among their recent research papers are:

  • Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial (2020, The Lancet)
  • Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies (2020, Journal of the American Academy of Dermatology)
  • Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures (2020, Journal of the American Academy of Dermatology)
  • Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial (2020, The Lancet)
  • Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials (2023, The Lancet)

Frequent co-authors in their work include:

  • Joseph F. Merola
  • Mark Lebwohl
  • Philip J. Mease
  • April W. Armstrong
  • Richard B. Warren

Best Publications

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

    Alan Menter;Alice Gottlieb;Steven R. Feldman;Abby S. Van Voorhees

  • Etanercept as monotherapy in patients with psoriasis

    Craig L. Leonardi;Jerold L. Powers;Robert T. Matheson;Bernard S. Goffe

  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Stephen Tyring;Alice Gottlieb;Kim Papp;Ken Gordon

  • Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

    U Chaudhari;P Romano;LD Mulcahy;LT Dooley

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics

    Alice Gottlieb;Neil J. Korman;Kenneth B. Gordon;Steven R. Feldman

  • Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

    Rachel M. Grossman;James Krueger;Debra Yourish;Angela Granelli-Piperno

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    Iain B McInnes;Philip J Mease;Bruce Kirkham;Arthur Kavanaugh

  • Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

    Alan Menter;Bruce E. Strober;Daniel H. Kaplan;Dario Kivelevitch

  • Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Iain B McInnes;Arthur Kavanaugh;Alice B Gottlieb;Lluís Puig

  • Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

    Christopher Ritchlin;Proton Rahman;Arthur Kavanaugh;Iain B McInnes

  • Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

    Alice Gottlieb;Alan Menter;Alan Mendelsohn;Yaung-Kaung Shen

  • Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

    Alice B. Gottlieb;Robert Evans;Shu Li;Lisa T. Dooley

  • Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

    Alexa B Kimball;Martin M Okun;David A Williams;Alice B Gottlieb

  • Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.

    Scott L. Gottlieb;Patricia Gilleaudeau;Ray Johnson;Len Estes

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis. Section 3. Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapies

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

    Alan Menter;Neil J. Korman;Craig A. Elmets;Steven R. Feldman

  • A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

    Alan Menter;Steven R. Feldman;Gerald D. Weinstein;Kim Papp

  • A Randomized Trial of Etanercept as Monotherapy for Psoriasis

    Alice B. Gottlieb;Robert T. Matheson;Nicholas Lowe;Gerald G. Krueger

Frequent Co-Authors

Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Philip J. Mease
Philip J. Mease University of Washington
Kenneth B. Gordon
Kenneth B. Gordon Medical College of Wisconsin
James G. Krueger
James G. Krueger Rockefeller University
Alan Menter
Alan Menter Texas A&M University
Craig L. Leonardi
Craig L. Leonardi Saint Louis University
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Arthur Kavanaugh
Arthur Kavanaugh University of California, San Diego
Kim Papp
Kim Papp Probity Medical Research
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open up rewarding career pathways beyond traditional medical school. One fast-growing field is healthcare administration. An online master of health administration offers flexibility for those who wish to lead and manage medical organizations without the time commitment of earning an MD.

Prospective students should consider financial factors when pursuing a graduate credential. The cost of mha degree programs can vary widely, but there are affordable options to suit various budgets, especially online.

Advanced nursing degrees are also in high demand. For nurses aiming to become leaders in healthcare practice and policy, the cheapest online dnp programs provide accessible pathways to a Doctor of Nursing Practice qualification.

Another related career route is pharmacy. Online education now makes it possible to pursue pharmd online programs, preparing graduates for pharmacy licensure and practice in a flexible format.

Whether you’re interested in administration, advanced nursing, or pharmacy, online degrees combine flexibility, affordability, and strong career prospects in the evolving health sector.

Best Scientists Citing Alice B. Gottlieb

Trending Scientists